Acadia Pharmaceuticals (ACAD) Times Interest Earned (2011 - 2026)
Acadia Pharmaceuticals' (ACAD) quarterly Times Interest Earned came in at -$0.78 in Q1 2026, down 358.82% year-on-year from $0.3 in Q1 2025, and down 114.33% quarter-over-quarter from $5.45 in Q4 2025.
Acadia Pharmaceuticals (ACAD) Times Interest Earned (2011 - 2026) Analysis & Trends
Acadia Pharmaceuticals' Times Interest Earned history runs 16 years deep, the most recent figure standing at -$0.78 for Q1 2026.
- On a quarterly basis, Times Interest Earned fell 358.82% year-over-year to -$0.78 in Q1 2026; TTM through Mar 2026 was $13.68, a 272.57% increase from a year earlier, with the FY2025 full-year figure at $1.32, down 87.9% from the prior year.
- Times Interest Earned declined to -$0.78 in Q1 2026 per ACAD's latest filing, from $5.45 in the prior quarter.
- Across five years, Times Interest Earned topped out at $59.64 in Q4 2024 and bottomed at -$19.51 in Q4 2022.
- The 5-year median for Times Interest Earned is $0.3 (2025), against an average of $3.33.
- Across the five-year window, Times Interest Earned tumbled 1697.47% in 2022 and surged 6853.33% in 2024, its largest moves.
- Year by year, Times Interest Earned stood at -$19.51 in 2022, then surged by 174.82% to $14.6 in 2023, then jumped by 308.56% to $59.64 in 2024, then sank by 90.87% to $5.45 in 2025, then plunged by 114.33% to -$0.78 in 2026.
- Per Business Quant, the three latest ACAD Times Interest Earned figures stand at -$0.78 (Q1 2026), $5.45 (Q4 2025), and $3.13 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Acadia Pharmaceuticals | 4.23 Bn | 3.38 Bn | 243.27 Mn | -0.78 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.78 |
| Dec 31, 2025 | 5.45 |
| Sep 30, 2025 | 3.13 |
| Jun 30, 2025 | 2.89 |
| Mar 31, 2025 | 0.30 |
| Dec 31, 2024 | 59.64 |
| Sep 30, 2024 | 3.90 |
| Jun 30, 2024 | 3.06 |
| Mar 31, 2024 | 1.53 |
| Dec 31, 2023 | 14.60 |
| Sep 30, 2023 | -0.87 |
| Jun 30, 2023 | 0.04 |
| Mar 31, 2023 | -0.75 |
| Dec 31, 2022 | -19.51 |
| Sep 30, 2022 | -3.44 |
| Jun 30, 2022 | -3.85 |
| Mar 31, 2022 | -8.79 |
| Dec 31, 2021 | -23.75 |
| Sep 30, 2021 | -0.19 |
| Jun 30, 2021 | -2.95 |